These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24152292)
1. Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. May JP; Ernsting MJ; Undzys E; Li SD Mol Pharm; 2013 Dec; 10(12):4499-508. PubMed ID: 24152292 [TBL] [Abstract][Full Text] [Related]
2. A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. Tagami T; May JP; Ernsting MJ; Li SD J Control Release; 2012 Jul; 161(1):142-9. PubMed ID: 22504351 [TBL] [Abstract][Full Text] [Related]
3. Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Jun; 152(2):303-9. PubMed ID: 21338635 [TBL] [Abstract][Full Text] [Related]
4. Smart thermosensitive liposomes for effective solid tumor therapy and in vivo imaging. Affram K; Udofot O; Singh M; Krishnan S; Reams R; Rosenberg J; Agyare E PLoS One; 2017; 12(9):e0185116. PubMed ID: 28934281 [TBL] [Abstract][Full Text] [Related]
5. Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system. Tagami T; Ernsting MJ; Li SD J Control Release; 2011 Sep; 154(3):290-7. PubMed ID: 21640149 [TBL] [Abstract][Full Text] [Related]
8. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Tagami T; Foltz WD; Ernsting MJ; Lee CM; Tannock IF; May JP; Li SD Biomaterials; 2011 Sep; 32(27):6570-8. PubMed ID: 21641639 [TBL] [Abstract][Full Text] [Related]
9. Current update of a thermosensitive liposomes composed of DPPC and Brij78. Ho L; Bokharaei M; Li SD J Drug Target; 2018; 26(5-6):407-419. PubMed ID: 29325469 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy of gemcitabine-loaded temperature-sensitive liposome by hyperthermia in tumor-bearing mice. Lim SK; Shin DH; Choi MH; Kim JS Drug Dev Ind Pharm; 2014 Apr; 40(4):470-6. PubMed ID: 23614830 [TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-loaded DSPE-PEG-PheoA liposome as a photomediated immune modulator for cholangiocarcinoma treatment. Kim DH; Im BN; Hwang HS; Na K Biomaterials; 2018 Nov; 183():139-150. PubMed ID: 30170256 [TBL] [Abstract][Full Text] [Related]
12. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921 [TBL] [Abstract][Full Text] [Related]
13. Multifunctional Liposomes for Image-Guided Intratumoral Chemo-Phototherapy. Miranda D; Carter K; Luo D; Shao S; Geng J; Li C; Chitgupi U; Turowski SG; Li N; Atilla-Gokcumen GE; Spernyak JA; Lovell JF Adv Healthc Mater; 2017 Aug; 6(16):. PubMed ID: 28504409 [TBL] [Abstract][Full Text] [Related]
14. Materials characterization of the low temperature sensitive liposome (LTSL): effects of the lipid composition (lysolipid and DSPE-PEG2000) on the thermal transition and release of doxorubicin. Needham D; Park JY; Wright AM; Tong J Faraday Discuss; 2013; 161():515-34; discussion 563-89. PubMed ID: 23805756 [TBL] [Abstract][Full Text] [Related]
15. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213 [TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies. Tang Z; Feng W; Yang Y; Wang Q Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830 [TBL] [Abstract][Full Text] [Related]
17. Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Milla P; Zanon C Pancreas; 2006 Jan; 32(1):44-50. PubMed ID: 16340743 [TBL] [Abstract][Full Text] [Related]
18. Poly (l-glutamic acid)-g-methoxy poly (ethylene glycol)-gemcitabine conjugate improves the anticancer efficacy of gemcitabine. Yang C; Song W; Zhang D; Yu H; Yin L; Shen N; Deng M; Tang Z; Gu J; Chen X Int J Pharm; 2018 Oct; 550(1-2):79-88. PubMed ID: 30138704 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol derivative-based liposomes for gemcitabine delivery: preparation, in vitro, and in vivo characterization. Li T; Chen L; Deng Y; Liu X; Zhao X; Cui Y; Shi J; Feng R; Song Y Drug Dev Ind Pharm; 2017 Dec; 43(12):2016-2025. PubMed ID: 28760000 [TBL] [Abstract][Full Text] [Related]
20. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability. Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]